01141nam a2200289 i 450099100279121970753620020508210032.0981218s1966 de ||| | ger b11060761-39ule_instPARLA169080ExLDip. di Filol. Class. e di Scienze Filosoficheita475Kühner, Raphael391913Elementar-, Formen- und Wortlehre /Raphael Kühner, Friedrich Holzweissig2. ed.Hannover :Hahn,1966xvi, 1127 p. ;24 cmAusführliche Grammatik der lateinischen Sprache ;1Rist. anast. della 2. ed.: Hannover 1912.Lingua latina - GrammaticaHolzweissig, Friedrichauthorhttp://id.loc.gov/vocabulary/relators/aut187715.b1106076123-02-1728-06-02991002791219707536LE007 b 4296/112007000042755le007-E0.00-no 00000.i1118700128-06-02Elementar-, Formen- und Wortlehre1088794UNISALENTOle00701-01-98ma -gerde 0103031nam 2200877z- 450 991055710720332120210501(CKB)5400000000040975(oapen)https://directory.doabooks.org/handle/20.500.12854/69370(oapen)doab69370(EXLCZ)99540000000004097520202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarriermTOR Signaling in Metabolism and CancerBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 online resource (204 p.)3-03943-553-1 3-03943-554-X The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in this Special Issue summarize the current understanding of the mTOR pathway and its role in the regulation of tissue regeneration, regulatory T cell differentiation and function, and different types of cancer including hematologic malignancies, skin, prostate, breast, and head and neck cancer. The findings highlight that targeting mTOR pathway is a promising strategy to fight against certain human diseases.MedicinebicsscAcute Lymphoblastic leukemiaadhesionAktbasal cell carcinomabiomarkerscancerscell metabolismcell signallingclinical trialscombinationeribulineverolimusFoxp3head and neck cancerhematologic malignancieshistone deacetylaseinhibitorsintegrinsintestineinvasionlivermelanomaMerkel cell carcinomametabolismmTORmTOR signalingmTOR signallingmusclemutant genesneuronphotodynamic therapyphytochemicalsPI3KPI3K/AKT/mTORprostate cancerregulatory T cellsskin cancerssquamous cell carcinomasynergyT cellstargeted therapiestargeted therapytissue regenerationTNBCtumorMedicineHuang Shileedt1325337Huang ShileothBOOK9910557107203321MTOR Signaling in Metabolism and Cancer3036762UNINA